title: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
authors.forename: John J V
authors.initials: JJ
authors.lastname: McMurray
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: Angelyn M
authors.initials: AM
authors.lastname: Bethel
authors.forename: Steven M
authors.initials: SM
authors.lastname: Haffner
authors.forename: Rury R
authors.initials: RR
authors.lastname: Holman
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D057186:Comparative Effectiveness Research / Q000379:methods*; D003920:Diabetes Mellitus / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents